GSK plc American Depositary Shares (Each representing two Ordina GSK
Open calendar →GSK plc American Depositary Shares (Each representing two Ordinary Shares) · Company · NYSE · Healthcare / Drug Manufacturers - General
Paper trade (simulated — no real money)
Fill: USD 50.7500 · FX 1 USD = 1.277900 SGD · about SGD 64.8534 per unitSign in to place simulated trades. USD fills are converted into the SGD portfolio at the displayed rate.
USD closing-price chart (daily close from yfinance · Last year)
USD 45.54 → 50.75 · 11.4%
Numbered dotted lines mark the filtered filings under Announcement Events below.
Price & SEC Filing History 23 Oct 2025 — 24 Oct 2026 (Last year)
Daily NYSE prices are sourced from yfinance. Yellow highlighting marks an intraday rise or a gap up between adjacent trading sessions. SEC acceptance times are converted to US Eastern time: pre-market filings appear below that day’s OHLCV row; filings accepted after the 09:30 ET open appear above it. The SEC does not publish an exact first-public-availability timestamp, so acceptance time is the best available proxy.
Date
Open
High
Low
Close
Volume
Weekend
50.8300
50.9200
50.2900
50.7500
3,165,743
50.2900
51.4400
49.9700
51.2100
4,283,400
96 · 6-K
After market open · 10:14 ET
US FDA APPROVES HIBSAGO FOR CHRONIC HEPATITIS B ↗
50.1900
50.4500
49.9100
50.0200
3,614,100
49.9800
51.1200
49.7700
50.6300
5,597,200
95 · 6-K
After-hours · 17:06 ET
JEMPERLI APPROVED IN MSI-H/DMMR RECTAL CANCER ↗
94 · 6-K
After market open · 11:25 ET
RIS-REZ POSITIVE EARLY DATA IN LUNG CANCER ↗
49.4400
49.8100
49.2600
49.4600
5,372,900
Weekend
Weekend
49.6200
49.9700
49.4400
49.5100
6,923,500
93 · 6-K
After market open · 14:47 ET
DIRECTOR/PDMR SHAREHOLDING ↗
49.1800
49.8400
48.9800
49.0200
6,141,500
92 · 6-K
After market open · 15:42 ET
DIRECTOR/PDMR SHAREHOLDING ↗
46.6300
47.9800
46.5500
47.8700
7,087,500
91 · 6-K
After market open · 15:12 ET
DIRECTOR/PDMR SHAREHOLDING ↗
90 · 6-K
After market open · 10:27 ET
DIRECTOR/PDMR SHAREHOLDING ↗
47.0900
47.1500
46.1100
46.2700
5,756,400
46.7000
47.0900
46.3100
46.9200
10,345,400
Weekend
Weekend
46.6100
46.8200
46.2700
46.5000
8,542,700
89 · 6-K
After market open · 15:42 ET
WENDY BECKER CBE - NEW DIRECTORSHIP ↗
46.4000
46.7000
45.8300
46.5400
7,730,500
46.9200
47.4100
46.6900
47.0200
5,852,600
88 · 6-K
After market open · 14:43 ET
ADMISSION TO TRADING ↗
46.9600
47.0100
46.1800
46.6000
6,806,400
46.7300
46.8900
46.3300
46.5500
3,480,400
Weekend
Weekend
47.0800
47.1600
46.8400
47.0300
5,385,700
87 · 6-K
After market open · 14:57 ET
TOTAL VOTING RIGHTS ↗
48.1600
48.2300
47.1300
47.1800
7,896,400
48.9300
49.0500
48.1700
48.1700
5,852,300
49.4100
49.8200
48.9600
49.3500
2,892,700
49.1700
49.8000
48.9800
49.7000
3,586,600
Weekend
Weekend
49.4900
49.5000
49.0000
49.2400
3,324,000
86 · 6-K
After market open · 14:44 ET
DIRECTOR/PDMR SHAREHOLDING ↗
49.5900
50.1400
49.5700
49.6500
2,838,900
50.1800
50.7400
49.6700
49.7100
3,040,700
85 · 6-K
After market open · 10:52 ET
DIRECTOR/PDMR SHAREHOLDING ↗
50.6900
50.9900
50.2200
50.7200
4,296,100
50.7500
51.3200
50.4600
51.0800
2,872,100
Weekend
Weekend
50.2000
50.3300
49.5000
50.2200
4,708,700
50.7200
51.0800
50.6200
51.0600
3,075,200
50.1900
50.7100
50.0600
50.2900
2,844,200
83 · 6-K
After market open · 12:12 ET
6-K ↗
49.6900
50.1600
49.6300
50.0100
2,739,700
84 · 6-K
Pre-market · 06:01 ET
GSK TO ACQUIRE T CELL-ENGAGER FOR MULTIPLE MYELOMA ↗
50.2900
50.3000
49.6100
50.0500
3,004,100
82 · 6-K
Pre-market · 07:24 ET
RIS-REZ POSITIVE PH 3 OS LUNG CANCER DATA IN CHINA ↗
81 · 6-K
Pre-market · 07:04 ET
JIDEYTRO POSITIVE DATA FOR ROS1-POSITIVE NSCLC ↗
Weekend
Weekend
80 · 6-K
After market open · 10:30 ET
DIRECTOR/PDMR SHAREHOLDING ↗
48.7000
48.8000
47.8500
48.1300
2,277,000
79 · 6-K
After market open · 10:31 ET
DIRECTOR/PDMR SHAREHOLDING ↗
48.4700
48.5900
47.9800
48.1200
2,151,000
78 · 6-K
Pre-market · 06:09 ET
JAPAN APPROVAL OF SHINGRIX IN A PREFILLED SYRINGE ↗
77 · 424B2
Pre-market · 08:53 ET
424B2 ↗
76 · 6-K
After market open · 10:45 ET
DIRECTOR/PDMR SHAREHOLDING ↗
75 · 6-K
After market open · 10:31 ET
DIRECTOR/PDMR SHAREHOLDING ↗
48.8200
49.1600
48.6000
48.6300
2,405,200
49.0000
49.2300
48.5400
48.5400
3,062,100
74 · 424B2
Pre-market · 09:06 ET
424B2 ↗
73 · 6-K
Pre-market · 08:27 ET
6-K ↗
No trading
Weekend
Weekend
49.7000
50.0600
49.6600
49.8900
2,286,800
51.5000
51.5200
50.1900
50.8700
2,443,300
50.3600
51.0800
50.0400
50.4400
2,938,400
72 · 6-K
After market open · 12:26 ET
TOTAL VOTING RIGHTS ↗
51.1100
51.2600
50.4700
50.6600
3,272,100
71 · 6-K
Pre-market · 07:46 ET
MRNA FLU VACCINE CANDIDATE TO ADVANCE TO PHASE III ↗
50.6200
50.8200
50.2500
50.2500
2,394,000
Weekend
Weekend
50.2200
50.8800
49.9500
50.8200
3,432,100
50.9500
51.0300
50.1700
50.2700
2,466,200
70 · 6-K
After market open · 10:37 ET
DIRECTOR/PDMR SHAREHOLDING ↗
51.9000
52.0900
51.4000
51.4300
1,716,700
51.5700
52.2100
51.5100
52.0700
2,699,100
69 · 6-K
After market open · 10:35 ET
DIRECTOR/PDMR SHAREHOLDING ↗
51.5400
51.9500
51.4000
51.7800
2,886,100
68 · 6-K
Pre-market · 06:57 ET
FIRST GLOBAL APPROVAL FOR HIBSAGO IN JAPAN ↗
67 · 6-K
Pre-market · 06:20 ET
US FDA TO REVIEW JEMPERLI FOR RECTAL CANCER ↗
Weekend
Weekend
51.3500
52.5700
51.3500
52.4100
2,404,700
52.5700
52.6300
51.8600
51.9600
3,598,400
51.4000
52.9500
51.3500
52.8800
3,902,400
66 · 6-K
After market open · 10:34 ET
DIRECTOR/PDMR SHAREHOLDING ↗
50.7600
51.3500
50.6500
51.1500
2,829,000
49.9300
50.3700
49.8800
50.2800
2,815,000
Weekend
Weekend
49.0400
49.5700
48.8600
49.5200
3,722,700
65 · 6-K
After market open · 11:33 ET
DIRECTOR/PDMR SHAREHOLDING ↗
50.5600
50.6300
50.1800
50.4500
2,692,500
50.1100
50.4700
49.8600
50.3000
4,093,100
64 · 6-K
After market open · 11:03 ET
DIRECTOR/PDMR SHAREHOLDING ↗
51.9500
52.3600
50.9000
50.9000
2,924,300
51.5300
52.2000
51.4700
52.1600
3,136,200
Weekend
Weekend
52.7100
53.0900
52.4200
52.9600
2,521,700
52.4400
52.5700
51.8900
52.1700
2,506,600
52.0600
52.1200
51.3600
51.4600
2,483,300
51.4700
51.7100
50.9300
51.5300
4,558,700
63 · 6-K
After market open · 11:16 ET
TOTAL VOTING RIGHTS ↗
52.1000
52.2700
51.0500
51.5100
4,530,800
Weekend
Weekend
51.9500
51.9800
51.3800
51.6900
3,982,200
62 · 6-K
After market open · 12:25 ET
DIRECTOR/PDMR SHAREHOLDING ↗
52.3300
52.7000
51.8700
52.0700
6,110,400
53.9400
53.9600
52.6600
53.2200
6,308,800
61 · 6-K
After market open · 13:10 ET
NEW GSK FLAGSHIP R&D CENTRE IN CAMBRIDGE ↗
60 · 6-K
After market open · 13:03 ET
HANSOH POSITIVE 2ND PHASE III RESULTS FOR RIZ-REZ ↗
59 · 6-K
After market open · 12:50 ET
2ND QUARTER RESULTS ↗
54.2400
55.7900
53.6000
53.7100
8,292,200
52.0400
52.6700
51.7300
51.9800
5,503,000
Weekend
Weekend
58 · 6-K
After market open · 10:39 ET
DIRECTOR/PDMR SHAREHOLDING ↗
57 · 6-K
After market open · 10:12 ET
ADMISSION TO TRADING ↗
51.4000
51.5700
51.0000
51.3500
5,863,100
50.0200
50.8700
49.8900
50.7400
4,120,600
56 · 6-K
After market open · 12:52 ET
JIDEYTRO APPROVED IN US FOR CERTAIN LUNG CANCERS ↗
51.7300
51.8300
50.6800
50.7600
3,976,600
50.2600
51.3100
50.1600
50.7800
3,901,400
55 · 6-K
After market open · 10:13 ET
BEXSERO 1-DOSE BOOSTER EMA FILE ACCEPTANCE ↗
51.3800
51.6700
50.0100
50.0400
5,345,200
Weekend
Weekend
51.0700
52.2700
51.0400
51.7600
10,759,700
54 · 6-K
Pre-market · 07:14 ET
AUDIT TENDER CONCLUSION ↗
53 · 6-K
Pre-market · 06:50 ET
CAMLIPIXANT PHASE III RESULTS UPDATE ↗
52 · 6-K
After market open · 10:45 ET
DIRECTOR/PDMR SHAREHOLDING ↗
51.4800
52.8500
51.4000
52.7700
3,978,500
51.2200
51.8200
51.0800
51.4500
2,800,200
51 · 6-K
Pre-market · 09:11 ET
GSK COMPLETES ACQUISITION OF NUVALENT, INC ↗
50 · SC TO-T/A
Pre-market · 09:00 ET
SC TO-T/A ↗
49 · 6-K
After market open · 11:20 ET
DIRECTOR/PDMR SHAREHOLDING ↗
51.8200
51.9500
51.0500
51.2500
3,315,300
48 · 6-K
After market open · 11:28 ET
DIRECTOR/PDMR SHAREHOLDING ↗
51.9700
52.6800
51.7500
52.2900
2,050,800
47 · 6-K
Pre-market · 06:29 ET
POSITIVE JEMPERLI DATA IN DMMR/MSI-H RECTAL CANCER ↗
Weekend
Weekend
52.9800
53.0600
52.3100
52.7800
2,867,700
46 · 6-K
Pre-market · 08:13 ET
HANSOH POSITIVE PHASE III RESULTS FOR RIZ-REZ ↗
45 · SC TO-T/A
Pre-market · 08:44 ET
SC TO-T/A ↗
44 · 6-K
After market open · 11:27 ET
DIRECTOR/PDMR SHAREHOLDING ↗
52.5500
52.8500
52.3000
52.4700
2,358,100
43 · 6-K
Pre-market · 07:27 ET
DIRECTORATE CHANGE ↗
52.6800
53.0200
52.4600
52.5200
3,083,500
42 · SC TO-T/A
After-hours · 16:44 ET
SC TO-T/A ↗
54.1500
54.2900
53.1400
53.3200
3,673,200
53.8000
53.8000
52.4500
53.0900
3,776,800
Weekend
Weekend
No trading
52.4200
53.8400
52.2500
53.6600
3,802,600
41 · 6-K
After market open · 10:02 ET
TOTAL VOTING RIGHTS ↗
52.2000
52.2500
51.0800
51.3000
3,202,600
52.5900
52.6900
51.5100
52.4200
4,011,100
40 · 6-K
After market open · 10:25 ET
TRANSACTION IN OWN SHARES ↗
39 · 6-K
After market open · 10:20 ET
HOLDING(S) IN COMPANY ↗
52.4800
52.9300
52.1100
52.8100
4,183,300
Weekend
Weekend
38 · 6-K
After market open · 10:02 ET
HOLDING(S) IN COMPANY ↗
51.6400
52.7200
51.6100
52.5000
4,205,000
51.9600
52.4800
51.7200
51.8900
3,575,400
37 · 6-K
After market open · 10:46 ET
DIRECTOR/PDMR SHAREHOLDING ↗
36 · 6-K
After market open · 10:39 ET
GSK ANNOUNCES TENDER OFFER TO ACQUIRE NUVALENT ↗
35 · SC TO-T/A
After-hours · 16:03 ET
SC TO-T/A ↗
52.1500
52.2000
51.0200
51.0900
3,669,900
34 · SC TO-T
Pre-market · 07:15 ET
SC TO-T ↗
33 · 6-K
After market open · 11:05 ET
DIRECTOR/PDMR SHAREHOLDING ↗
51.6300
52.1200
51.5100
52.0700
3,008,300
32 · 6-K
After market open · 11:00 ET
TRANSACTION IN OWN SHARES ↗
50.7900
51.1800
50.5900
50.7400
3,735,200
Weekend
Weekend
No trading
51.7900
51.9400
50.4300
50.6700
4,219,100
31 · 6-K
After market open · 12:02 ET
CUTI ORAL ANTIBIOTIC TEBIPENEM APPROVED BY US FDA ↗
52.4800
52.8200
51.7900
52.1500
4,016,800
52.6200
52.7200
52.0100
52.2200
3,853,900
30 · 6-K
After market open · 10:02 ET
TRANSACTION IN OWN SHARES ↗
52.9300
53.2100
52.1700
52.2300
3,434,100
Weekend
Weekend
53.1300
53.4500
52.8900
53.0400
3,805,900
29 · 6-K
Pre-market · 06:32 ET
MOMELOTINIB ORPHAN DRUG DESIGNATIONS FOR VEXAS ↗
28 · 6-K
After market open · 10:42 ET
DIRECTOR/PDMR SHAREHOLDING ↗
52.1800
53.2100
52.0800
52.8600
5,018,400
27 · 6-K
After market open · 10:36 ET
DIRECTOR/PDMR SHAREHOLDING ↗
26 · SC TO-C
After-hours · 16:54 ET
SC TO-C ↗
51.3200
51.6200
50.9900
51.1700
5,075,900
25 · 6-K
After market open · 13:37 ET
DR HAL BARRON - NEW DIRECTORSHIP ↗
23 · SC TO-C
After-hours · 17:20 ET
SC TO-C ↗
50.4300
51.3400
50.3500
51.2500
6,115,400
24 · 6-K
Pre-market · 06:18 ET
GSK ENTERS AGREEMENT TO ACQUIRE NUVALENT, INC. ↗
22 · SC TO-C
Pre-market · 07:13 ET
SC TO-C ↗
21 · 6-K
After-hours · 16:08 ET
TRANSACTION IN OWN SHARES ↗
50.9900
51.3800
50.4600
50.6400
4,836,400
Weekend
Weekend
51.4200
51.9700
51.2700
51.5200
4,048,100
50.8100
51.2700
50.7100
51.2700
3,894,000
49.4700
49.8900
49.3900
49.7200
3,811,700
48.9500
49.3600
48.5700
49.0000
2,942,000
20 · 6-K
After market open · 10:46 ET
TOTAL VOTING RIGHTS ↗
19 · 6-K
After market open · 10:00 ET
TRANSACTION IN OWN SHARES ↗
49.9800
50.1400
49.1800
49.3100
4,073,400
Weekend
Weekend
51.0700
51.2600
50.5100
50.5400
2,797,600
51.3500
51.9400
51.2100
51.2400
3,965,300
18 · 6-K
Pre-market · 06:02 ET
POSITIVE PHASE 3 DATA FOR BEPIROVIRSEN ↗
17 · 6-K
After market open · 10:34 ET
DIRECTOR/PDMR SHAREHOLDING ↗
51.7800
52.1100
51.5500
51.5800
3,066,600
16 · 6-K
After market open · 10:23 ET
ADMISSION TO TRADING ↗
15 · 6-K
After market open · 10:17 ET
TRANSACTION IN OWN SHARES ↗
51.8700
51.9000
51.1200
51.5000
2,835,500
No trading
Weekend
Weekend
51.5600
51.8000
51.1400
51.3800
3,153,600
14 · 6-K
Pre-market · 07:19 ET
Q2 2026 RESULTS DATE CONFIRMED - 28 JULY 2026 ↗
50.8400
51.7700
50.5900
51.5300
2,102,400
13 · 6-K
After market open · 10:40 ET
DIRECTOR/PDMR SHAREHOLDING ↗
12 · 6-K
After market open · 10:39 ET
DIRECTOR/PDMR SHAREHOLDING ↗
51.1400
51.2700
50.6800
50.7800
2,898,700
11 · 6-K
After market open · 11:01 ET
DIRECTOR/PDMR SHAREHOLDING ↗
50.4200
51.2600
50.4100
51.0500
3,834,700
10 · 6-K
After market open · 11:03 ET
TRANSACTION IN OWN SHARES ↗
49.7900
50.5300
49.7900
50.2600
3,108,000
9 · 6-K
Pre-market · 06:29 ET
JAPAN MHLW APPROVES AREXVY FOR ADULTS 18-49 AIR ↗
Weekend
Weekend
50.1500
50.2500
49.3900
49.6700
3,915,000
8 · 6-K
After market open · 12:22 ET
DIRECTOR/PDMR SHAREHOLDING ↗
51.2400
51.3100
50.7900
50.9600
3,536,000
50.3300
51.2500
50.2500
50.9900
4,114,200
50.5400
51.1900
50.3400
50.9000
4,848,600
7 · 6-K
After market open · 10:59 ET
DIRECTOR/PDMR SHAREHOLDING ↗
50.6500
50.9200
49.7100
49.8100
3,575,200
6 · 6-K
Pre-market · 06:42 ET
COLLABORATION WITH CTTQ FOR BEPIROVIRSEN ↗
5 · 6-K
Pre-market · 06:31 ET
GSK - FINAL TRANCHE OF SHARE BUYBACK PROGRAMME ↗
Weekend
Weekend
50.5100
50.5700
50.0500
50.4100
2,409,300
50.8200
50.8200
50.4200
50.5000
3,403,300
4 · 6-K
After market open · 13:52 ET
RESULT OF AGM ↗
51.0900
51.2200
50.5200
50.5300
3,897,600
3 · 6-K
After market open · 12:54 ET
DIRECTOR/PDMR SHAREHOLDING ↗
50.4500
50.6500
50.0200
50.3800
3,521,800
51.5200
51.6100
50.7900
50.9000
3,202,800
Weekend
Weekend
2 · 6-K
After market open · 11:11 ET
TOTAL VOTING RIGHTS ↗
1 · 6-K
After market open · 11:08 ET
HOLDING(S) IN COMPANY ↗
51.8000
52.2300
51.5200
51.6100
3,938,100
51.9100
52.6300
51.6300
52.3100
5,147,900
50.0000
52.1300
49.9900
51.4000
11,238,500
54.3700
55.0200
54.1800
54.4700
6,751,700
54.2100
54.7900
54.1800
54.2200
3,084,600
Weekend
Weekend
55.2200
55.2700
54.1900
54.4400
5,048,800
55.9800
56.1900
55.5100
55.6300
3,454,000
56.2900
56.3400
55.6800
55.7000
3,584,500
56.4800
56.5100
55.9500
56.1200
3,998,800
58.1700
58.2700
57.3000
57.3500
3,662,100
Weekend
Weekend
57.6900
58.3600
57.4300
58.3500
2,986,300
57.6400
57.7800
57.0800
57.1300
3,002,800
59.2800
59.2800
57.4800
57.8100
3,379,300
58.9600
59.5700
58.1400
59.1800
3,753,500
58.3800
58.9800
58.1600
58.9400
4,153,300
Weekend
Weekend
59.0500
59.0600
58.1900
58.2100
4,407,500
57.1500
58.6600
57.0100
58.3600
3,465,800
57.0300
57.4100
56.5100
57.3700
3,809,500
55.8800
55.9600
55.1100
55.8400
3,845,900
56.6500
56.7600
56.1900
56.3700
2,051,500
Weekend
Weekend
No trading
56.0100
57.1800
55.9300
56.6900
3,877,300
55.5200
56.4600
55.4100
55.9900
6,253,900
54.7400
55.2500
54.3700
55.1900
5,532,300
54.6400
54.6500
54.0700
54.2300
3,361,400
Weekend
Weekend
54.2300
54.7500
53.7900
53.8400
3,034,200
54.5800
54.8800
53.8600
53.9400
6,556,600
54.3900
54.9800
54.0700
54.7000
5,306,100
51.7900
53.1000
51.7100
52.9500
4,778,500
52.1900
52.6900
51.8000
51.9900
4,333,600
Weekend
Weekend
52.1700
52.4000
51.5500
51.8400
4,637,100
51.7200
52.6900
51.6500
52.3700
3,990,400
52.8800
52.8800
51.7800
52.0600
4,654,600
53.7300
53.9900
53.3700
53.4100
3,404,000
54.2100
54.5800
53.7000
53.7700
4,149,000
Weekend
Weekend
54.4800
54.7300
53.3700
53.3900
4,661,200
54.5700
54.5700
53.7700
54.2800
5,329,600
55.3000
55.5600
54.7900
55.1500
5,396,000
55.5300
56.0500
55.1000
55.3200
5,365,300
54.3600
55.5800
53.9200
55.5100
5,966,800
Weekend
Weekend
54.4100
54.9200
54.0700
54.5100
6,192,600
56.0300
56.0800
54.7200
55.2700
6,887,600
57.0200
57.0300
56.2900
56.8300
3,815,100
56.8200
57.3500
56.1600
57.0700
3,913,800
58.5600
58.8700
58.0000
58.2900
3,167,700
Weekend
Weekend
58.4300
59.3600
58.3300
59.1300
5,981,900
59.0000
59.0700
58.0500
58.0700
6,224,200
59.6700
59.9400
59.4900
59.5400
4,627,100
59.5100
59.8200
59.0900
59.1200
5,755,800
59.2700
59.7100
59.0200
59.2600
6,849,200
Weekend
Weekend
59.8700
60.0500
59.3300
59.5200
7,219,700
60.9300
61.0600
59.9800
60.8500
4,868,400
61.5400
61.7000
60.9900
61.1800
5,389,800
60.5000
61.0300
60.0600
60.8700
5,675,100
No trading
Weekend
Weekend
58.8700
59.1700
58.5600
58.9300
6,280,800
58.4300
58.6200
58.0500
58.5400
6,244,500
58.7400
58.9200
58.0200
58.4900
6,951,400
59.2400
59.3200
58.1900
58.8200
9,503,900
59.9200
59.9400
58.6100
59.0100
8,070,900
Weekend
Weekend
59.2900
60.3700
59.2500
60.2300
8,148,900
57.7900
59.6200
57.7300
59.1700
13,085,100
56.5600
57.6200
56.3300
57.2300
10,897,000
52.4900
53.3800
52.4300
53.3400
6,205,900
52.1700
52.6700
52.1300
52.4700
4,151,200
Weekend
Weekend
51.1400
51.6900
51.0600
51.6000
5,489,900
50.8200
51.0900
50.6300
50.6600
5,904,400
50.1700
50.6100
49.6000
50.1000
5,883,400
50.4900
51.3700
50.4900
50.8000
5,105,000
49.7700
50.5700
49.7400
50.3200
4,220,500
Weekend
Weekend
48.7400
49.1600
48.5700
49.1500
5,430,000
48.4100
48.7500
48.0800
48.6500
4,564,500
47.8500
48.3800
47.7700
48.0700
6,516,400
48.0500
48.3500
47.6200
47.6500
8,201,100
No trading
Weekend
Weekend
48.8500
48.9300
48.0900
48.2200
7,543,400
50.4800
50.5000
49.0700
49.1200
6,545,200
50.2000
50.8700
50.1600
50.7900
3,684,100
49.9300
50.0700
49.3200
49.9000
3,693,100
50.8000
50.8200
50.1700
50.3900
2,640,700
Weekend
Weekend
50.4300
50.8100
50.3600
50.3900
3,925,700
50.8000
51.2700
50.0200
50.2200
4,406,900
50.6900
51.3900
50.5600
50.6200
5,205,100
50.6900
51.4600
50.3400
50.5600
5,923,800
49.5000
49.5700
48.5900
49.0200
5,277,900
Weekend
Weekend
49.2300
49.6300
49.0700
49.6300
3,486,000
No trading
49.2000
49.2400
48.9300
49.0400
1,584,800
49.3000
49.4000
49.1400
49.3000
1,833,500
48.9200
49.2400
48.9200
49.1100
1,820,800
Weekend
Weekend
48.9700
49.1300
48.8500
49.0800
1,207,500
No trading
48.7200
49.0400
48.6900
48.9600
1,064,900
48.9900
49.2300
48.7200
48.8500
2,857,600
48.6500
48.8800
48.5000
48.5900
2,602,800
Weekend
Weekend
48.2100
48.9300
48.1500
48.6100
3,286,400
48.4000
48.6900
48.2400
48.2900
3,470,100
49.3500
49.4400
48.6800
48.7100
5,257,600
49.2800
49.3600
48.5200
48.7800
3,800,700
48.9100
49.3900
48.9000
49.2400
4,059,100
Weekend
Weekend
48.9000
48.9900
48.5600
48.8100
2,972,500
48.4600
48.9700
48.4500
48.8800
3,871,100
48.0400
48.4400
47.8200
48.4100
2,988,000
48.0100
48.2900
47.2000
47.2700
3,782,600
48.3900
48.5800
48.1500
48.4700
4,354,000
Weekend
Weekend
48.7700
48.8500
48.0100
48.4100
2,380,400
48.9500
49.0600
48.5300
48.5700
3,326,100
48.9500
49.3100
48.8000
48.9700
3,696,000
48.0900
48.4100
47.7800
48.2700
4,840,400
48.0600
48.0800
47.1300
47.1900
3,663,200
Weekend
Weekend
47.8800
47.9000
47.4200
47.8600
2,851,800
No trading
48.0400
48.3600
47.9800
48.0200
4,282,100
47.3500
47.9200
47.3100
47.5500
6,602,200
47.0300
47.3400
46.8600
46.9900
5,306,100
Weekend
Weekend
46.4900
47.3200
46.4700
47.1900
4,235,300
46.6000
46.6000
45.8100
46.1100
6,208,600
47.0200
47.0800
46.3200
46.3400
6,213,100
47.0300
47.4800
46.9600
47.3700
4,635,000
47.6000
47.9800
47.4200
47.5300
3,735,100
Weekend
Weekend
47.3200
47.5700
47.1000
47.1800
5,054,200
48.0200
48.6900
48.0100
48.1400
4,035,800
47.7600
48.3100
47.5200
48.0700
3,565,900
47.8300
48.4800
47.8200
48.4100
3,916,100
46.7500
47.3700
46.5600
47.3600
2,861,700
Weekend
Weekend
46.7500
46.9300
46.3900
46.6300
5,552,900
46.8400
47.2100
46.6200
47.1000
4,212,600
46.5600
47.0400
46.5200
46.6900
5,525,000
46.0900
47.0200
45.9900
46.8200
5,065,300
46.7500
46.7500
46.2600
46.3500
4,764,800
Weekend
Weekend
46.8500
47.1200
46.5700
46.8600
5,027,400
45.9300
47.1600
45.8200
46.9400
8,724,800
46.0200
46.7100
45.5000
45.9300
13,924,300
44.0000
44.2400
42.8900
43.7000
8,410,100
43.8500
44.2200
43.6500
43.8000
5,573,100
Weekend
Weekend
43.7900
43.9900
42.8500
43.2400
9,860,100
43.9900
46.8700
43.9800
45.5400
7,897,600
Announcement Events
Each title opens the filing on the SEC website. Registered users can summarise the filing and up to seven relevant exhibits linked within the same SEC submission.
96
6-K
US FDA APPROVES HIBSAGO FOR CHRONIC HEPATITIS B (opens SEC filing in a new tab)
After market open · 10:14 ET
Summarise
95
6-K
JEMPERLI APPROVED IN MSI-H/DMMR RECTAL CANCER (opens SEC filing in a new tab)
After-hours · 17:06 ET
Summarise
94
6-K
RIS-REZ POSITIVE EARLY DATA IN LUNG CANCER (opens SEC filing in a new tab)
After market open · 11:25 ET
Summarise
93
6-K
DIRECTOR/PDMR SHAREHOLDING (opens SEC filing in a new tab)
After market open · 14:47 ET
Summarise
92
6-K
DIRECTOR/PDMR SHAREHOLDING (opens SEC filing in a new tab)
After market open · 15:42 ET
Summarise
91
6-K
DIRECTOR/PDMR SHAREHOLDING (opens SEC filing in a new tab)
After market open · 15:12 ET
Summarise
90
6-K
DIRECTOR/PDMR SHAREHOLDING (opens SEC filing in a new tab)
After market open · 10:27 ET
Summarise
89
6-K
WENDY BECKER CBE - NEW DIRECTORSHIP (opens SEC filing in a new tab)
After market open · 15:42 ET
Summarise
86
6-K
DIRECTOR/PDMR SHAREHOLDING (opens SEC filing in a new tab)
After market open · 14:44 ET
Summarise
85
6-K
DIRECTOR/PDMR SHAREHOLDING (opens SEC filing in a new tab)
After market open · 10:52 ET
Summarise
84
6-K
GSK TO ACQUIRE T CELL-ENGAGER FOR MULTIPLE MYELOMA (opens SEC filing in a new tab)
Pre-market · 06:01 ET
Summarise
82
6-K
RIS-REZ POSITIVE PH 3 OS LUNG CANCER DATA IN CHINA (opens SEC filing in a new tab)
Pre-market · 07:24 ET
Summarise
81
6-K
JIDEYTRO POSITIVE DATA FOR ROS1-POSITIVE NSCLC (opens SEC filing in a new tab)
Pre-market · 07:04 ET
Summarise
80
6-K
DIRECTOR/PDMR SHAREHOLDING (opens SEC filing in a new tab)
After market open · 10:30 ET
Summarise
79
6-K
DIRECTOR/PDMR SHAREHOLDING (opens SEC filing in a new tab)
After market open · 10:31 ET
Summarise
78
6-K
JAPAN APPROVAL OF SHINGRIX IN A PREFILLED SYRINGE (opens SEC filing in a new tab)
Pre-market · 06:09 ET
Summarise
76
6-K
DIRECTOR/PDMR SHAREHOLDING (opens SEC filing in a new tab)
After market open · 10:45 ET
Summarise
75
6-K
DIRECTOR/PDMR SHAREHOLDING (opens SEC filing in a new tab)
After market open · 10:31 ET
Summarise
71
6-K
MRNA FLU VACCINE CANDIDATE TO ADVANCE TO PHASE III (opens SEC filing in a new tab)
Pre-market · 07:46 ET
Summarise
70
6-K
DIRECTOR/PDMR SHAREHOLDING (opens SEC filing in a new tab)
After market open · 10:37 ET
Summarise
69
6-K
DIRECTOR/PDMR SHAREHOLDING (opens SEC filing in a new tab)
After market open · 10:35 ET
Summarise
68
6-K
FIRST GLOBAL APPROVAL FOR HIBSAGO IN JAPAN (opens SEC filing in a new tab)
Pre-market · 06:57 ET
Summarise
67
6-K
US FDA TO REVIEW JEMPERLI FOR RECTAL CANCER (opens SEC filing in a new tab)
Pre-market · 06:20 ET
Summarise
66
6-K
DIRECTOR/PDMR SHAREHOLDING (opens SEC filing in a new tab)
After market open · 10:34 ET
Summarise
65
6-K
DIRECTOR/PDMR SHAREHOLDING (opens SEC filing in a new tab)
After market open · 11:33 ET
Summarise
64
6-K
DIRECTOR/PDMR SHAREHOLDING (opens SEC filing in a new tab)
After market open · 11:03 ET
Summarise
62
6-K
DIRECTOR/PDMR SHAREHOLDING (opens SEC filing in a new tab)
After market open · 12:25 ET
Summarise
61
6-K
NEW GSK FLAGSHIP R&D CENTRE IN CAMBRIDGE (opens SEC filing in a new tab)
After market open · 13:10 ET
Summarise
60
6-K
HANSOH POSITIVE 2ND PHASE III RESULTS FOR RIZ-REZ (opens SEC filing in a new tab)
After market open · 13:03 ET
Summarise
58
6-K
DIRECTOR/PDMR SHAREHOLDING (opens SEC filing in a new tab)
After market open · 10:39 ET
Summarise
56
6-K
JIDEYTRO APPROVED IN US FOR CERTAIN LUNG CANCERS (opens SEC filing in a new tab)
After market open · 12:52 ET
Summarise
55
6-K
BEXSERO 1-DOSE BOOSTER EMA FILE ACCEPTANCE (opens SEC filing in a new tab)
After market open · 10:13 ET
Summarise
53
6-K
CAMLIPIXANT PHASE III RESULTS UPDATE (opens SEC filing in a new tab)
Pre-market · 06:50 ET
Summarise
52
6-K
DIRECTOR/PDMR SHAREHOLDING (opens SEC filing in a new tab)
After market open · 10:45 ET
Summarise
51
6-K
GSK COMPLETES ACQUISITION OF NUVALENT, INC (opens SEC filing in a new tab)
Pre-market · 09:11 ET
Summarise
49
6-K
DIRECTOR/PDMR SHAREHOLDING (opens SEC filing in a new tab)
After market open · 11:20 ET
Summarise
48
6-K
DIRECTOR/PDMR SHAREHOLDING (opens SEC filing in a new tab)
After market open · 11:28 ET
Summarise
47
6-K
POSITIVE JEMPERLI DATA IN DMMR/MSI-H RECTAL CANCER (opens SEC filing in a new tab)
Pre-market · 06:29 ET
Summarise
46
6-K
HANSOH POSITIVE PHASE III RESULTS FOR RIZ-REZ (opens SEC filing in a new tab)
Pre-market · 08:13 ET
Summarise
44
6-K
DIRECTOR/PDMR SHAREHOLDING (opens SEC filing in a new tab)
After market open · 11:27 ET
Summarise
40
6-K
TRANSACTION IN OWN SHARES (opens SEC filing in a new tab)
After market open · 10:25 ET
Summarise
37
6-K
DIRECTOR/PDMR SHAREHOLDING (opens SEC filing in a new tab)
After market open · 10:46 ET
Summarise
36
6-K
GSK ANNOUNCES TENDER OFFER TO ACQUIRE NUVALENT (opens SEC filing in a new tab)
After market open · 10:39 ET
Summarise
33
6-K
DIRECTOR/PDMR SHAREHOLDING (opens SEC filing in a new tab)
After market open · 11:05 ET
Summarise
32
6-K
TRANSACTION IN OWN SHARES (opens SEC filing in a new tab)
After market open · 11:00 ET
Summarise
31
6-K
CUTI ORAL ANTIBIOTIC TEBIPENEM APPROVED BY US FDA (opens SEC filing in a new tab)
After market open · 12:02 ET
Summarise
30
6-K
TRANSACTION IN OWN SHARES (opens SEC filing in a new tab)
After market open · 10:02 ET
Summarise
29
6-K
MOMELOTINIB ORPHAN DRUG DESIGNATIONS FOR VEXAS (opens SEC filing in a new tab)
Pre-market · 06:32 ET
Summarise
28
6-K
DIRECTOR/PDMR SHAREHOLDING (opens SEC filing in a new tab)
After market open · 10:42 ET
Summarise
27
6-K
DIRECTOR/PDMR SHAREHOLDING (opens SEC filing in a new tab)
After market open · 10:36 ET
Summarise
25
6-K
DR HAL BARRON - NEW DIRECTORSHIP (opens SEC filing in a new tab)
After market open · 13:37 ET
Summarise
24
6-K
GSK ENTERS AGREEMENT TO ACQUIRE NUVALENT, INC. (opens SEC filing in a new tab)
Pre-market · 06:18 ET
Summarise
19
6-K
TRANSACTION IN OWN SHARES (opens SEC filing in a new tab)
After market open · 10:00 ET
Summarise
18
6-K
POSITIVE PHASE 3 DATA FOR BEPIROVIRSEN (opens SEC filing in a new tab)
Pre-market · 06:02 ET
Summarise
17
6-K
DIRECTOR/PDMR SHAREHOLDING (opens SEC filing in a new tab)
After market open · 10:34 ET
Summarise
15
6-K
TRANSACTION IN OWN SHARES (opens SEC filing in a new tab)
After market open · 10:17 ET
Summarise
14
6-K
Q2 2026 RESULTS DATE CONFIRMED - 28 JULY 2026 (opens SEC filing in a new tab)
Pre-market · 07:19 ET
Summarise
13
6-K
DIRECTOR/PDMR SHAREHOLDING (opens SEC filing in a new tab)
After market open · 10:40 ET
Summarise
12
6-K
DIRECTOR/PDMR SHAREHOLDING (opens SEC filing in a new tab)
After market open · 10:39 ET
Summarise
11
6-K
DIRECTOR/PDMR SHAREHOLDING (opens SEC filing in a new tab)
After market open · 11:01 ET
Summarise
10
6-K
TRANSACTION IN OWN SHARES (opens SEC filing in a new tab)
After market open · 11:03 ET
Summarise
9
6-K
JAPAN MHLW APPROVES AREXVY FOR ADULTS 18-49 AIR (opens SEC filing in a new tab)
Pre-market · 06:29 ET
Summarise
8
6-K
DIRECTOR/PDMR SHAREHOLDING (opens SEC filing in a new tab)
After market open · 12:22 ET
Summarise
7
6-K
DIRECTOR/PDMR SHAREHOLDING (opens SEC filing in a new tab)
After market open · 10:59 ET
Summarise
6
6-K
COLLABORATION WITH CTTQ FOR BEPIROVIRSEN (opens SEC filing in a new tab)
Pre-market · 06:42 ET
Summarise
5
6-K
GSK - FINAL TRANCHE OF SHARE BUYBACK PROGRAMME (opens SEC filing in a new tab)
Pre-market · 06:31 ET
Summarise